Skip to main content
  • Donate Blood (Opens in a new tab/window)
  • About NBA
  • News and updates
  • Resources
  • BloodPortal login (Opens in a new tab/window)
Logo image Logo image
  • Blood Products
    • Blood Products
    • National Product Price List
    • Fresh Blood Products
    • Albumin Products
    • Clotting Factor and Other Products
    • Immunoglobulin Products
      • Immunoglobulin Usage and Data
      • Intravenous Immunoglobulin (IVIg)
      • Subcutaneous Immunoglobulin (SCIg)
      • Normal Human Immunoglobulin (NHIg)
      • Hyperimmune Immunoglobulin Products
    • Access and Ordering
      • BloodSTAR for Ig Products
      • BloodSTAR Registration Form
      • BloodNet for Blood Products from Lifeblood
      • BloodNet System Interface
      • Frequently Asked Questions
    • Blood Product Management
      • Inventory Management
      • Blood Product Wastage
      • Blood and Inventory Management Resources
      • Case Studies
      • Single Unit Transfusion Guide
  • Supply System
    • Supply System
    • Managing Blood Supply
      • Risk Management
      • National Stewardship Program
      • Blood Product Labelling
    • Governance for Immunoglobulin Products
      • National Immunoglobulin Governance Committees
      • Criteria for Immunoglobulin Products
    • Suppliers and Commercial Supply Contracts
      • Fresh Blood Product Supply and Lifeblood
      • Plasma and Recombinant Product Supply
      • Imported Product Supply
      • Red Cell Diagnostic Product Supply
    • Australian Health Provider Access to Blood and Blood Products
    • Overseas Supply of Blood Products
  • Clinical Guidance
    • Clinical Guidance
      • Rh D Ig Guideline (Opens in a new tab/window)
      • PBM Guidelines (Opens in a new tab/window)
    • National Standards
    • Immunoglobulin
    • Patient Blood Management
      • Patient Blood Management (PBM) Resources
    • Transfusion-related Adverse Events
    • Bleeding Disorders
      • Australian Bleeding Disorders Registry (ABDR)
    • eLearning Courses
    • Public Consultations
    • Patient Blood Management Guidelines (Opens in a new tab/window)
  • Data and Research
    • Data and Research
    • Data and Reporting
    • Research Funding Program
      • Successful Grant Rounds
  • Patient Information
    • Patient information
    • Bleeding disorders
    • Blood disorders
    • Travelling with blood products
    • MyABDR app and the ABDR

Search

  • Donate Blood (Opens in a new tab/window)
  • About NBA
  • News and updates
  • Resources
  • BloodPortal login (Opens in a new tab/window)
  • Blood Products
    • Blood Products
    • National Product Price List
    • Fresh Blood Products
    • Albumin Products
    • Clotting Factor and Other Products
    • Immunoglobulin Products
      • Immunoglobulin Usage and Data
      • Intravenous Immunoglobulin (IVIg)
      • Subcutaneous Immunoglobulin (SCIg)
      • Normal Human Immunoglobulin (NHIg)
      • Hyperimmune Immunoglobulin Products
    • Access and Ordering
      • BloodSTAR for Ig Products
      • BloodSTAR Registration Form
      • BloodNet for Blood Products from Lifeblood
      • BloodNet System Interface
      • Frequently Asked Questions
    • Blood Product Management
      • Inventory Management
      • Blood Product Wastage
      • Blood and Inventory Management Resources
      • Case Studies
      • Single Unit Transfusion Guide
  • Supply System
    • Supply System
    • Managing Blood Supply
      • Risk Management
      • National Stewardship Program
      • Blood Product Labelling
    • Governance for Immunoglobulin Products
      • National Immunoglobulin Governance Committees
      • Criteria for Immunoglobulin Products
    • Suppliers and Commercial Supply Contracts
      • Fresh Blood Product Supply and Lifeblood
      • Plasma and Recombinant Product Supply
      • Imported Product Supply
      • Red Cell Diagnostic Product Supply
    • Australian Health Provider Access to Blood and Blood Products
    • Overseas Supply of Blood Products
  • Clinical Guidance
    • Clinical Guidance
      • Rh D Ig Guideline
      • PBM Guidelines
    • National Standards
    • Immunoglobulin
    • Patient Blood Management
      • Patient Blood Management (PBM) Resources
    • Transfusion-related Adverse Events
    • Bleeding Disorders
      • Australian Bleeding Disorders Registry (ABDR)
    • eLearning Courses
    • Public Consultations
    • Patient Blood Management Guidelines
  • Data and Research
    • Data and Research
    • Data and Reporting
    • Research Funding Program
      • Successful Grant Rounds
  • Patient Information
    • Patient information
    • Bleeding disorders
    • Blood disorders
    • Travelling with blood products
    • MyABDR app and the ABDR

Our people

  • Home
  • Our people

About our organisation

As a small independent agency, our team directly contributes to improving patients' lives and outcomes in a challenging and ever-changing industry.

We are organised into 2 groups:

  • Commercial Blood Products and Business Services
  • Fresh Blood Products and Business Systems.

Each group has its own program and business responsibilities. A Deputy Chief Executive oversees each group's activities.

Our Chief Executive, Adriana Platona, is the accountable authority for the NBA.

  • EMG Org chart.pdf
    156.66 KB

Our executive team

Adjunct Professor Adriana Platona PSM, Chief Executive

Adjunct Professor Adriana Platona PSM is the Chief Executive of the National Blood Authority (NBA). She is a distinguished public sector leader recognised with the Public Service Medal for her outstanding service in public health.

Adjunct Professor Platona has more than two decades of senior leadership experience in the Australian Department of Health, Disability and Ageing, where she worked across health and ageing portfolios. She has led major reforms in policy, governance, and service delivery, and is widely respected for her expertise in leadership, strategy, and public administration.

Ms Kate McCauley, Deputy Chief Executive, Fresh Blood Products and Business Systems

Ms McCauley became Deputy Chief Executive, Fresh Blood Products and Business Systems, in November 2022. She has wide-ranging capabilities in organisational change and reform, health-related policy and service delivery. She is an experienced Senior Executive Service officer who has worked in several areas of government, including the health and education portfolios and with central agencies. Her early career as a registered nurse gives her a unique understanding of the practical implications of government decision-making and policy implementation.

Ms McCauley's NBA responsibilities cover fresh blood products and services and related issues. This includes coordinating the national supply planning processes across Australia. She has principal executive responsibility for our contract with Australian Red Cross Lifeblood. She also has executive responsibility for the Chief Information Officer group, our ICT and data management activities, and coordination of our corporate risk management work.

Mr Ben Noyen, Deputy Chief Executive, Commercial Blood Products and Business Services

Mr Noyen was appointed as the Deputy Chief Executive, Commercial Blood Products and Business Services in mid-November 2023. He is an experienced senior executive and leader with a background in health policy, compliance and regulation, manufacturing and corporate operations. Originally an industrial engineer, Mr Noyen’s experience prior to government extends to private sector roles in business consulting, fraud and risk management. Earlier in his career, he served as a police officer.

In the National Blood Authority, Mr Noyen is responsible for the commercial strategy and supply of plasma-derived products, recombinant and other alternative blood products. In addition, he leads the national Immunoglobulin Governance Program and manages the assessment and funding of new products. Mr Noyen is also responsible for national blood sector research and development, along with the National Blood Authority’s business services that includes finance, legal services, human resources and communications.

NBA Board

Our board advises the Chief Executive about how the NBA is performing. Its members also consider key strategic issues in Australia's blood sector.

NBA Board

Get in touch

For more information about our people, contact us.

Last updated: 27 Mar 2024

Back to top

The National Blood Authority acknowledges the Traditional Owners and Custodians of Country throughout Australia, and their continuing connection to land, water and community. We pay our respects to the people, the cultures and the elders past, present and emerging.

National Blood Authority

  • About the NBA
  • Work with us
  • Contact Us
  • Data and reporting
  • Freedom of information
  • Public interest disclosure
  • Resources
  • Accessibility
  • Privacy
  • Copyright
  • Disclaimer
  • BloodPortal Terms and Conditions of Use

Information

  • Blood Products
  • Managing blood supply
  • Supply systems
  • Clinical guidance
  • Patient information
  • Data and research
  • Website feedback